Global Mechanical Thrombectomy Devices Market Driven by Innovation: Set to Surge with 6% Growth in the Next 5 Years
Growing number of cases of stroke and venous thromboembolism (deep vein thrombosis and pulmonary embolism), as well as the approval/launch of novel mechanical thrombectomy devices, favorable clinical trial outcomes with mechanical thrombectomy, and acquisitions by leading players to strengthen their vascular portfolio and treat patients with blood clots, are driving the growth of the mechanical thrombectomy devices market. Blood clots are a prevalent medical problem that need rapid medical intervention. Mechanical thrombectomy devices are utilized in operations to treat blood clot-caused arterial blockages. Mechanical thrombectomy can be used to treat ischemic stroke, pulmonary embolism (PE), and deep vein thrombosis (DVT). Technological Advances in Mechanical Thrombectomy Drive Market Growth for Mechanical Thrombectomy Devices Constant technical advances and innovations are projected to drive the global mechanical thrombectomy devices market. As an example, In April 2022, Penum...